Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Colitis Suppositories versus mesalazine suppositories in mild-to-moderate active ulcerative colitis
ChiCTR2000028869Phase 2Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jan 2020
- Countries
- 1
01
Overview
Phase 2 trial of Colitis Suppositories in autoimmune colitis (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Clinical efficacy rate at week 8, Incidence of adverse events and adverse reactions and 10 more. Started Jan 2020; status: recruiting.
02
Drugs
Colitis Suppositories
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ChiCTR2000028869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028869.